These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3880556)

  • 1. A therapeutic index that predicts the individual effects of prednisone in patients with cirrhosis.
    Christensen E; Schlichting P; Andersen PK; Fauerholdt L; Juhl E; Poulsen H; Tygstrup N
    Gastroenterology; 1985 Jan; 88(1 Pt 1):156-65. PubMed ID: 3880556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables.
    Christensen E; Schlichting P; Andersen PK; Fauerholdt L; Schou G; Pedersen BV; Juhl E; Poulsen H; Tygstrup N
    Scand J Gastroenterol; 1986 Mar; 21(2):163-74. PubMed ID: 3520795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in cirrhosis identified by Cox's regression model.
    Schlichting P; Christensen E; Andersen PK; Fauerholdt L; Juhl E; Poulsen H; Tygstrup N
    Hepatology; 1983; 3(6):889-95. PubMed ID: 6354903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases.
    Lancet; 1969 Jan; 1(7586):119-21. PubMed ID: 4178242
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone.
    Copenhagen Study Group for Liver Diseases
    N Engl J Med; 1974 Aug; 291(6):271-3. PubMed ID: 4600899
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance.
    Christensen E; Schlichting P; Fauerholdt L; Juhl E; Poulsen H; Tygstrup N
    Hepatology; 1985; 5(5):843-53. PubMed ID: 2411649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatment.
    Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):113-8. PubMed ID: 7176840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment.
    Schlichting P; Juhl E; Poulsen H; Winkel P
    Scand J Gastroenterol; 1976; 11(3):305-12. PubMed ID: 775615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prednisone treatment of liver cirrhosis].
    Ugeskr Laeger; 1974 Jul; 136(30):1673-6. PubMed ID: 4428503
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of prednisone on serum cholesterol in patients with cirrhosis of the liver.
    Boberg F; Hattel T; Nielsen OE
    Scand J Gastroenterol; 1972; 7(8):723-6. PubMed ID: 4565595
    [No Abstract]   [Full Text] [Related]  

  • 12. Individual therapy-dependent prognosis based on data from controlled clinical trials in chronic liver disease.
    Christensen E
    Dan Med Bull; 1988 Apr; 35(2):167-82. PubMed ID: 3282812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving proportional hazards.
    Elashoff JD
    Hepatology; 1983; 3(6):1031-5. PubMed ID: 6354901
    [No Abstract]   [Full Text] [Related]  

  • 14. Main causes of death in cirrhosis.
    Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N
    Scand J Gastroenterol; 1983 Oct; 18(7):881-8. PubMed ID: 6374868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causes of death in prednisone treated and control patients with cirrhosis.
    Sloth K; Juhl E; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():189-93. PubMed ID: 5271843
    [No Abstract]   [Full Text] [Related]  

  • 16. A biomedical computer programme system for controlled trials.
    Juhl E; Winkel P; Frank H; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():195-201. PubMed ID: 4917039
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of selection in controlled clinical trials. A supplement to the CSL prednisone trial in cirrhosis.
    Juhl E; Hilden M; Tygstrup N
    Scand J Gastroenterol Suppl; 1971; 9():171-5. PubMed ID: 5284140
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of prognostic factors in cirrhosis.
    Wang JY; Liu HY; Zhu WN; Han JQ; Dong CY; Shi YJ; Cai HJ; Cao JM; Yi QL
    Chin Med J (Engl); 1989 Apr; 102(4):266-72. PubMed ID: 2507240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current problems in clinical aspects and therapy of liver cirrhosis].
    Pfleiderer T
    Wien Med Wochenschr; 1970 Sep; 120(38):635-40. PubMed ID: 5518114
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion of micronodular cirrhosis into macronodular cirrhosis.
    Fauerholdt L; Schlichting P; Christensen E; Poulsen H; Tygstrup N; Juhl E
    Hepatology; 1983; 3(6):928-31. PubMed ID: 6629323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.